Orforglipron
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Eli Lilly · Phase 1 · Completed · Enrollment 50
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cohort 1: Oral Drug Dosing With or Without Orforglipron Co-Administration | Obesity or overweight | n/r | 24 | n/r | n/r |
| Cohort 2: Oral Drug Dosing With or Without Orforglipron Co-Administration | Obesity or overweight | n/r | 24 | n/r | n/r |